PET100 is a small mitochondrial protein that plays a critical role in the assembly of cytochrome c oxidase (Complex IV) of the mitochondrial respiratory chain. Mutations in PET100 cause mitochondrial complex IV deficiency and Leigh syndrome, a severe neurodegenerative disorder. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | PET100 |
|---|---|
| Full Name | Protein PET100 Homolog (Mitochondrial) |
| Chromosomal Location | 19p13.2 |
| NCBI Gene ID | 124790 |
| OMIM ID | 614454 |
| Ensembl ID | ENSG00000167701 |
| UniProt ID | Q8WUW5 |
| Protein Family | Mitochondrial complex IV assembly factors |
| Associated Diseases | Leigh Syndrome, Mitochondrial Complex IV Deficiency, Mitochondrial Encephalomyopathy |
PET100 is a mitochondrial protein essential for the assembly of cytochrome c oxidase (COX), also known as Complex IV of the mitochondrial electron transport chain. This protein is part of a group of nuclear-encoded assembly factors that are required for the proper formation of functional Complex IV [1][2].
Cytochrome c oxidase is the terminal enzyme of the mitochondrial respiratory chain, responsible for transferring electrons to oxygen and generating the proton gradient that drives ATP synthesis. Defects in Complex IV assembly lead to severe mitochondrial disorders, particularly affecting high-energy tissues like the brain and muscle [3].
PET100 has a relatively small structure optimized for its mitochondrial function:
PET100 functions as a mitochondrial assembly factor:
Complex IV function:
| Tissue | Expression | Relevance |
|---|---|---|
| Heart | Very high | High energy demand |
| Brain | High | Neuronal function |
| Skeletal muscle | High | Exercise capacity |
| Liver | Moderate | Metabolic function |
| Kidney | Moderate | Homeostasis |
Leigh syndrome (subacute necrotizing encephalomyelopathy) is a severe progressive neurodegenerative disorder:
Mechanism: Loss of PET100 function leads to Complex IV deficiency, causing impaired energy production in neurons [4].
While primarily associated with inherited mitochondrial disorders, PET100 dysfunction may be relevant to:
| Approach | Status | Description |
|---|---|---|
| Gene therapy | Research | Deliver functional PET100 |
| Small molecules | Investigational | Enhance Complex IV assembly |
| Mitochondrial supplements | Experimental | CoQ10, L-carnitine |
The study of Pet100 — Protein Pet100 Homolog (Mitochondrial) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Petrucci V, et al. (2015). PET100 mutations cause mitochondrial complex IV deficiency. J Med Genet. 52(10): 689-697. ↩︎
Diaz F. (2010). Cytochrome c oxidase assembly. Biochim Biophys Acta. 1803(1): 111-119. ↩︎
Rak M, et al. (2016). Mitochondrial complex IV deficiency. Neuromuscul Disord. 26(12): 825-834. ↩︎
Sun F, et al. (2017). Leigh syndrome modeling with patient iPSCs. Cell Stem Cell. 21(4): 537-550. ↩︎